Keyphrases
Radiation Therapy
100%
Radiation Therapy Oncology Group
100%
Validation Studies
100%
High-grade Prostate Cancer
100%
Response to Radiation
100%
Biochemical Recurrence-free Survival
100%
Immune State
100%
C-reactive Protein
57%
Interleukin-10
57%
Interleukin-1β
28%
Interferon-α (IFN-α)
28%
Interleukin-6
28%
Interleukin-13 (IL-13)
28%
Serum Samples
28%
Adjusted Hazard Ratio
28%
Distant Metastasis
28%
Interleukin-2
28%
Negatively Associated
28%
Interleukin-23 (IL-23)
28%
Tumor Necrosis Factor-α
14%
Confidence Interval
14%
Hazard Ratio
14%
Interleukin-12 (IL-12)
14%
Clinical Outcomes
14%
Odds Ratio
14%
Non-associated
14%
Adjusted Odds Ratio
14%
Low Dose Rate
14%
Overall Survival
14%
Interleukin-8
14%
Interleukin-17 (IL-17)
14%
Poor Outcome
14%
Granulocyte Colony-stimulating Factor (G-CSF)
14%
Monocyte Chemoattractant protein-1 (MCP-1)
14%
Interleukin-5 (IL-5)
14%
Interleukin-4 (IL-4)
14%
Erectile Dysfunction
14%
Inflammatory State
14%
Prospective Evaluation
14%
C-reactive Protein Level
14%
Biomarker Validation
14%
Immuno-inflammatory Response
14%
Pollakiuria
14%
Multiplicity Adjustment
14%
Medicine and Dentistry
Prostate Cancer
100%
Oncology
100%
Radiation Therapy
100%
Disease Free Survival
87%
C Reactive Protein
62%
Interleukin 10
50%
Cytokine
37%
Hazard Ratio
37%
Interferon
25%
Interleukin 13
25%
Interleukin 6
25%
Distant Metastasis
25%
Interleukin 2
25%
Interleukin 23
25%
Odds Ratio
25%
Biological Marker
12%
Tumor Necrosis Factor
12%
Interleukin 12
12%
Overall Survival
12%
Erectile Dysfunction
12%
Interleukin 5
12%
Monocyte Chemotactic Protein 1
12%
Interleukin 4
12%
Interleukin 17
12%
Granulocyte Macrophage Colony Stimulating Factor
12%
Interleukin 8
12%
Pollakisuria
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Disease Free Survival
100%
C Reactive Protein
71%
Interleukin 10
57%
Cytokine
42%
Interferon
28%
Distant Metastasis
28%
Interleukin 6
28%
Interleukin 2
28%
Interleukin 13
28%
Interleukin 23
28%
Tumor Necrosis Factor
14%
Biological Marker
14%
Overall Survival
14%
Granulocyte Macrophage Colony Stimulating Factor
14%
Erectile Dysfunction
14%
Interleukin 5
14%
Monocyte Chemotactic Protein 1
14%
Interleukin 4
14%
Interleukin 12
14%
Interleukin 17
14%
Interleukin 8
14%
Pollakisuria
14%
Immunology and Microbiology
Disease Free Survival
100%
C-Reactive Protein
71%
Interleukin 10
57%
Cytokine
42%
interferon
28%
Interleukin 13
28%
Interleukin 6
28%
Interleukin 2
28%
Interleukin 23
28%
Tumor Necrosis Factor
14%
Overall Survival
14%
Monocyte Chemotactic Protein 1
14%
Interleukin 4
14%
Interleukin 5
14%
Granulocyte Macrophage Colony-Stimulating Factor
14%
Interleukin 17
14%
Interleukin 8
14%
Interleukin 12
14%
Neuroscience
Radiation Therapy
100%
C-Reactive Protein
62%
Interleukin 10
50%
Interferon
25%
Interleukin 6
25%
Interleukin 2
25%
Interleukin
25%
Interleukin 13
25%
Interleukin 23
25%
Granulocyte Macrophage Colony-Stimulating Factor
12%
Interleukin 4
12%
Necrosis
12%
Interleukin 17
12%
Interleukin 12
12%
Monocyte Chemotactic Protein 1
12%
Interleukin 5
12%
Interleukin 8
12%
Food Science
Colony Stimulating Factor
100%